The incidence of cytomegalovirus disease is not increased after OKT3 induction therapy.
Lake
K
K
Anderson
D
D
Milfred
S
S
Love
K
K
Pritzker
M
M
Emery
R
R
D003586:Cytomegalovirus Infections / Q000209:etiology*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3